ivacaftor
The following drugs will decrease ivacaftor effect
# | enzyme | inducers |
0 | 3A457 | barbiturates |
1 | 3A457 | brigatinib |
2 | 3A457 | carbamazepine |
3 | 3A457 | clobazam |
4 | 3A457 | dabrafenib |
5 | 3A457 | efavirenz |
6 | 3A457 | elagolix |
7 | 3A457 | enzalutamide |
8 | 3A457 | eslicarbazepine |
9 | 3A457 | glucocorticoids |
10 | 3A457 | letermovir |
11 | 3A457 | lorlatinib |
12 | 3A457 | modafinil |
13 | 3A457 | nevirapine |
14 | 3A457 | oxcarbazepine |
15 | 3A457 | perampanel |
16 | 3A457 | phenobarbital |
17 | 3A457 | phenytoin |
18 | 3A457 | pioglitazone |
19 | 3A457 | rifabutin |
20 | 3A457 | rifampin |
21 | 3A457 | St. John's Wort |
22 | 3A457 | telotristat |
23 | 3A457 | troglitazone |
24 | 3A457 | vemurafenib |
the follwing drugs will
Increase ivacaftor effect
# | enzyme | Inhibitors | level |
0 | 3A457 | amiodarone | under review |
1 | 3A457 | aprepitant | Moderate inhibitor |
2 | 3A457 | atomoxetine | |
3 | 3A457 | boceprevir | under review |
4 | 3A457 | ceritinib | Strong inhibitor |
5 | 3A457 | chloramphenicol | In-Vitro Only |
6 | 3A457 | cimetidine | |
7 | 3A457 | ciprofloxacin | under review |
8 | 3A457 | clarithromycin | Strong inhibitor |
9 | 3A457 | crizotinib | Moderate inhibitor |
10 | 3A457 | delaviridine | under review |
11 | 3A457 | diethyl-dithiocarbamate | |
12 | 3A457 | diltiazem | Moderate inhibitor |
13 | 3A457 | entrectinib | |
14 | 3A457 | erythromycin | Moderate inhibitor |
15 | 3A457 | esomeprazole | |
16 | 3A457 | fluconazole | Moderate inhibitor |
17 | 3A457 | fluvoxamine | under review |
18 | 3A457 | gestodene | under review |
19 | 3A457 | grapefruit juice | Moderate inhibitor |
20 | 3A457 | idelalisib | Strong inhibitor |
21 | 3A457 | imatinib | under review |
22 | 3A457 | indinavir | Strong inhibitor |
23 | 3A457 | itraconazole | Strong inhibitor |
24 | 3A457 | ivacaftor | |
25 | 3A457 | ketoconazole | Strong inhibitor |
26 | 3A457 | lesinurad | |
27 | 3A457 | letermovir | |
28 | 3A457 | mibefradil | Strong inhibitor |
29 | 3A457 | mifepristone | under review |
30 | 3A457 | nefazodone | Strong inhibitor |
31 | 3A457 | nelfinavir | Strong inhibitor |
32 | 3A457 | netupitant/palonosetron | Moderate inhibitor |
33 | 3A457 | norfloxacin | under review |
34 | 3A457 | norfluoxetine | under review |
35 | 3A457 | omeprazole | Weak inhibitor |
36 | 3A457 | pantoprazole | |
37 | 3A457 | perampanel | |
38 | 3A457 | quercetin | |
39 | 3A457 | regorafenib | under review |
40 | 3A457 | ribociclib | Strong inhibitor |
41 | 3A457 | ritonavir | Strong inhibitor |
42 | 3A457 | rucaparib | |
43 | 3A457 | saquinavir | Strong inhibitor |
44 | 3A457 | simeprevir | |
45 | 3A457 | starfruit | under review |
46 | 3A457 | telaprevir | under review |
47 | 3A457 | telithromycin | Strong inhibitor |
48 | 3A457 | ticagrelor | |
49 | 3A457 | tucatinib | Strong inhibitor |
50 | 3A457 | verapamil | Moderate inhibitor |
51 | 3A457 | voriconazole | Strong inhibitor |
The follwing drugs will Increase effect by ivacaftor effect
# | enzyme | drug | level |
1 | 3A457 | abemaciclib | |
2 | 3A457 | abiraterone | |
3 | 3A457 | acalabrutinib | |
4 | 3A457 | alectinib | |
5 | 3A457 | alfentanil | |
6 | 3A457 | alprazolam | |
7 | 3A457 | amitriptyline | |
8 | 3A457 | amlodipine | |
9 | 3A457 | apixaban | |
10 | 3A457 | aprepitant | |
11 | 3A457 | aripiprazole | |
12 | 3A457 | astemizole | |
13 | 3A457 | atorvastatin | |
14 | 3A457 | avanafil | |
15 | 3A457 | axitinib | |
16 | 3A457 | boceprevir | |
17 | 3A457 | bosutinib | |
18 | 3A457 | brexpiprazole | |
19 | 3A457 | brigatinib | |
20 | 3A457 | buspirone | |
21 | 3A457 | cafergot | |
22 | 3A457 | caffeine | |
23 | 3A457 | carbamazepine | |
24 | 3A457 | cariprazine | |
25 | 3A457 | ceritinib | |
26 | 3A457 | cerivastatin | |
27 | 3A457 | chlorpheniramine | |
28 | 3A457 | cilostazol | |
29 | 3A457 | cisapride | |
30 | 3A457 | citalopram | |
31 | 3A457 | clarithromycin | |
32 | 3A457 | clobazam | |
33 | 3A457 | clopidogrel | |
34 | 3A457 | cobimetinib | |
35 | 3A457 | cocaine | |
36 | 3A457 | codeine | |
37 | 3A457 | colchicine | |
38 | 3A457 | copanlisib | |
39 | 3A457 | crizotinib | |
40 | 3A457 | cyclosporine | |
41 | 3A457 | dabrafenib | |
42 | 3A457 | daclatasvir | |
43 | 3A457 | dapsone | |
44 | 3A457 | deflazacort | |
45 | 3A457 | dexamethasone | |
46 | 3A457 | dextromethorphan | |
47 | 3A457 | diazepam | |
48 | 3A457 | diltiazem | |
49 | 3A457 | docetaxel | |
50 | 3A457 | dolutegravir | |
51 | 3A457 | domperidone | |
52 | 3A457 | doxepin | |
53 | 3A457 | elagolix | |
54 | 3A457 | elbasvir/grazoprevir | |
55 | 3A457 | eliglustat | |
56 | 3A457 | enzalutamide | |
57 | 3A457 | eplerenone | |
58 | 3A457 | erythromycin2 | |
59 | 3A457 | escitalopram | |
60 | 3A457 | esomeprazole | |
61 | 3A457 | estradiol | |
62 | 3A457 | felodipine | |
63 | 3A457 | fentanyl | |
64 | 3A457 | finasteride | |
65 | 3A457 | flibanserin | |
66 | 3A457 | gleevec | |
67 | 3A457 | haloperidol | |
68 | 3A457 | hydrocortisone | |
69 | 3A457 | ibrutinib | |
70 | 3A457 | idelalisib | |
71 | 3A457 | indacaterol | |
72 | 3A457 | indinavir | |
73 | 3A457 | irinotecan | |
74 | 3A457 | isavuconazonium | |
75 | 3A457 | ivabradine | |
76 | 3A457 | ivacaftor | |
77 | 3A457 | LAAM | |
78 | 3A457 | lansoprazole | |
79 | 3A457 | lenvatinib | |
80 | 3A457 | lercanidipine | |
81 | 3A457 | lidocaine | |
82 | 3A457 | linagliptin | |
83 | 3A457 | lovastatin | |
84 | 3A457 | macitentan | |
85 | 3A457 | mavacamten | |
86 | 3A457 | methadone | |
87 | 3A457 | midazolam | |
88 | 3A457 | naldemedine | |
89 | 3A457 | naloxegol | |
90 | 3A457 | nateglinide | |
91 | 3A457 | nelfinavir | |
92 | 3A457 | neratinib | |
93 | 3A457 | netupitant/palonosetron | |
94 | 3A457 | nevirapine | |
95 | 3A457 | nifedipine | |
96 | 3A457 | nirmatrelvir | |
97 | 3A457 | nisoldipine | |
98 | 3A457 | nitrendipine | |
99 | 3A457 | olaparib | |
100 | 3A457 | omeprazole | |
101 | 3A457 | ondansetron | |
102 | 3A457 | osimertinib | |
103 | 3A457 | ospemifene | |
104 | 3A457 | palbociclib | |
105 | 3A457 | panobinostat | |
106 | 3A457 | pantoprazole | |
107 | 3A457 | perampanel | |
108 | 3A457 | pimavanserin | |
109 | 3A457 | pimozide | |
110 | 3A457 | pomalidomide | |
111 | 3A457 | ponatinib | |
112 | 3A457 | progesterone | |
113 | 3A457 | propranolol | |
114 | 3A457 | quetiapine | |
115 | 3A457 | quinidine | |
116 | 3A457 | quinine | |
117 | 3A457 | regorafenib | |
118 | 3A457 | ribociclib | |
119 | 3A457 | rilpivirine | |
120 | 3A457 | risperidone | |
121 | 3A457 | ritonavir | |
122 | 3A457 | rivaroxaban | |
123 | 3A457 | roflumilast | |
124 | 3A457 | rolapitant | |
125 | 3A457 | romidepsin | |
126 | 3A457 | rucaparib | |
127 | 3A457 | ruxolitinib | |
128 | 3A457 | salmeterol | |
129 | 3A457 | saquinavir | |
130 | 3A457 | selexipag | |
131 | 3A457 | sildenafil | |
132 | 3A457 | simeprevir | |
133 | 3A457 | simvastatin | |
134 | 3A457 | sirolimus | |
135 | 3A457 | sonidegib | |
136 | 3A457 | sorafenib | |
137 | 3A457 | sunitinib | |
138 | 3A457 | suvorexant | |
139 | 3A457 | tacrolimus(fk506) | |
140 | 3A457 | tamoxifen | |
141 | 3A457 | tasimelteon | |
142 | 3A457 | taxol | |
143 | 3A457 | telaprevir | |
144 | 3A457 | telithromycin | |
145 | 3A457 | terfenadine | |
146 | 3A457 | testosterone | |
147 | 3A457 | ticagrelor | |
148 | 3A457 | tofacitinib | |
149 | 3A457 | tolvaptan | |
150 | 3A457 | torisel | |
151 | 3A457 | tramadol | |
152 | 3A457 | trazodone | |
153 | 3A457 | valbenazine | |
154 | 3A457 | vandetanib | |
155 | 3A457 | velpatasvir | |
156 | 3A457 | vemurafenib | |
157 | 3A457 | venetoclax | |
158 | 3A457 | venlafaxine | |
159 | 3A457 | verapamil | |
160 | 3A457 | vilazodone | |
161 | 3A457 | vincristine | |
162 | 3A457 | vorapaxar | |
163 | 3A457 | voriconazole | |
164 | 3A457 | zaleplon | |
165 | 3A457 | ziprasidone | |
166 | 3A457 | zolpidem | |
will
decrease ivacaftor effect
ivacaftor will not affect
Strong inhibitor is one that causes a ≥ 5-fold decrease in the plasma AUC values or more than 80% decrease in clearance.
Moderate inhibitor is one that causes a 2 fold to < 5-fold decrease in the plasma AUC values or 50-80% decrease in clearance.
Weak inhibitor is one that causes a ≥ 1.25-fold but < 2-fold decrease in the plasma AUC values or 20-50% decrease in clearance.
In-Vitro Only In-Vitro Only Inhibitor strength.
under review Inhibitor strength level is under review.